title: Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France.
authors.affiliation: Optum, Nanterre, France.
authors.forename: N
authors.initials: N
authors.lastname: Despiégel
authors.affiliation: AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
authors.forename: A G
authors.initials: AG
authors.lastname: Marcellin
authors.affiliation: Glaxo Smith Kline, Marly-le-Roi, France.
authors.forename: C
authors.initials: C
authors.lastname: Aubin
authors.affiliation: Optum, Nanterre, France.
authors.forename: C
authors.initials: C
authors.lastname: Espinas
authors.affiliation: ViiV Healthcare France, Marly-le-Roi, France.
authors.forename: A
authors.initials: A
authors.lastname: Laurisse
authors.affiliation: APHP, Hôpital Tenon, Paris, France.
authors.forename: G
authors.initials: G
authors.lastname: Pialoux